文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Managing cardiovascular risk factors: the gap between evidence and practice.管理心血管危险因素：证据与实践之间的差距。

PLoS Med. 2005 May;2(5):e131. doi: 10.1371/journal.pmed.0020131. Epub 2005 May 31.

2

Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs.循证处方：将网络荟萃分析与多标准决策分析相结合以在多种药物中进行选择。

Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):787-92. doi: 10.1161/CIRCOUTCOMES.114.000825. Epub 2014 Aug 5.

3

Miracle or mirage?奇迹还是幻影？

Nurs Stand. 2007;21(47):18-20. doi: 10.7748/ns.21.47.18.s25.

4

Prescribing Statins to Reduce Cardiovascular Disease: 10 Common Misconceptions.开具他汀类药物以降低心血管疾病风险：10个常见误解。

Am J Med. 2019 Aug;132(8):897-899. doi: 10.1016/j.amjmed.2019.01.042. Epub 2019 Mar 6.

5

Why are statin prescribing guidelines for primary prevention not always followed in primary care?为何基层医疗中他汀类药物用于一级预防的处方指南并非总能得到遵循？

Br J Gen Pract. 2016 Oct;66(651):536-7. doi: 10.3399/bjgp16X687481.

6

Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care setting.使用合并队列风险评分是否会高估他汀类药物的使用情况？一项在初级保健机构开展的回顾性队列研究。

BMC Fam Pract. 2014 Nov 12;15:172. doi: 10.1186/s12875-014-0172-y.

7

Statins and safety: applying the results of randomized trials to clinical practice.

Am J Cardiol. 2003 Sep 15;92(6):692-5. doi: 10.1016/s0002-9149(03)00825-7.

8

Assessment of Primary Care Appointment Times and Appropriate Prescribing of Statins for At-Risk Patients.评估初级保健预约时间和为高危患者适当开具他汀类药物。

JAMA Netw Open. 2021 May 3;4(5):e219050. doi: 10.1001/jamanetworkopen.2021.9050.

9

Inequality in provision of medical care in Sweden: a case of social epidemiological hypochondria?

J Epidemiol Community Health. 2010 Aug;64(8):651-2. doi: 10.1136/jech.2009.094011.

10

Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry.临床医生报告的血脂指南采纳是否转化为遵循指南的护理？对患者和提供者血脂管理评估（PALM）登记处的评估。

Am Heart J. 2018 Jun;200:118-124. doi: 10.1016/j.ahj.2018.03.011. Epub 2018 Mar 24.

引用本文的文献

1

Umami and saltiness enhancements of vegetable soup by enzyme-produced glutamic acid and branched-chain amino acids.酶法生产的谷氨酸和支链氨基酸对蔬菜汤鲜味和咸味的增强作用。

Front Nutr. 2024 Aug 19;11:1436113. doi: 10.3389/fnut.2024.1436113. eCollection 2024.

2

A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension.一项评估氨氯地平/瑞舒伐他汀固定剂量复方制剂在血脂异常和高血压患者中的疗效和安全性的随机、双盲临床试验。

J Clin Hypertens (Greenwich). 2020 Feb;22(2):261-269. doi: 10.1111/jch.13774. Epub 2020 Jan 31.

3

Validation of preferred salt concentration in soup based on a randomized blinded experiment in multiple regions in Japan-influence of umami (L-glutamate) on saltiness and palatability of low-salt solutions.基于在日本多个地区进行的随机双盲实验验证汤品的最佳盐浓度——鲜味（L-谷氨酸）对低盐溶液咸味和口感的影响。

Hypertens Res. 2020 Jun;43(6):525-533. doi: 10.1038/s41440-020-0397-1. Epub 2020 Jan 29.

4

Introducing a model of cardiovascular prevention in Nairobi's slums by integrating a public health and private-sector approach: the SCALE-UP study.通过整合公共卫生和私营部门的方法，在肯尼亚内罗毕的贫民窟引入心血管预防模式：SCALE-UP 研究。

Glob Health Action. 2013 Oct 21;6:22510. doi: 10.3402/gha.v6i0.22510.

5

The effects of Hartcoach, a life style intervention provided by telephone on the reduction of coronary risk factors: a randomised trial.哈特蔻驰生活方式干预通过电话减少冠心病危险因素的效果：一项随机试验。

BMC Cardiovasc Disord. 2012 Jun 26;12:47. doi: 10.1186/1471-2261-12-47.

6

How do family physicians communicate about cardiovascular risk? Frequencies and determinants of different communication formats.家庭医生如何就心血管风险进行沟通？不同沟通形式的频率和决定因素。

BMC Fam Pract. 2011 Apr 5;12:15. doi: 10.1186/1471-2296-12-15.

7

Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial.氨氯地平和阿托伐他汀联合应用于高血压合并血脂异常患者的疗效和安全性：AVALON试验结果

J Clin Hypertens (Greenwich). 2006 Aug;8(8):571-81; quiz 582-3. doi: 10.1111/j.1524-6175.2006.05636.x.

8

Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention.基层医疗中的合理用药（RaPP）：一项量身定制干预措施的整群随机试验。

PLoS Med. 2006 Jun;3(6):e134. doi: 10.1371/journal.pmed.0030134.

本文引用的文献

1

National trends in statin use by coronary heart disease risk category.按冠心病风险类别划分的他汀类药物使用的全国趋势。

PLoS Med. 2005 May;2(5):e123. doi: 10.1371/journal.pmed.0020123. Epub 2005 May 31.

2

First-line first? Trends in thiazide prescribing for hypertensive seniors.一线治疗优先？老年高血压患者噻嗪类药物处方的趋势。

PLoS Med. 2005 Apr;2(4):e80. doi: 10.1371/journal.pmed.0020080. Epub 2005 Apr 26.

3

Intensive lipid lowering with atorvastatin in patients with stable coronary disease.阿托伐他汀强化降脂治疗稳定型冠心病患者

N Engl J Med. 2005 Apr 7;352(14):1425-35. doi: 10.1056/NEJMoa050461. Epub 2005 Mar 8.

4

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.不同降压方案对主要心血管事件的影响：前瞻性设计的随机试验综述结果

Lancet. 2003 Nov 8;362(9395):1527-35. doi: 10.1016/s0140-6736(03)14739-3.

5

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.2003年世界卫生组织（WHO）/国际高血压学会（ISH）关于高血压管理的声明。

J Hypertens. 2003 Nov;21(11):1983-92. doi: 10.1097/00004872-200311000-00002.

6

Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey.五个欧洲国家基层医疗医生对冠心病预防指南建议的接受情况及感知到的实施情况：重新评估欧洲对心血管治疗的态度（REACT）调查

Fam Pract. 2002 Dec;19(6):596-604. doi: 10.1093/fampra/19.6.596.

7

Risk factor thresholds: their existence under scrutiny.风险因素阈值：其存在受到审视。

BMJ. 2002 Jun 29;324(7353):1570-6. doi: 10.1136/bmj.324.7353.1570.

8

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).国家胆固醇教育计划（NCEP）成人高血胆固醇检测、评估与治疗专家小组第三次报告（成人治疗小组第三次报告）执行摘要

JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486.

管理心血管危险因素：证据与实践之间的差距。

Managing cardiovascular risk factors: the gap between evidence and practice.

作者信息

Turnbull Fiona

机构信息

George Institute for International Health, University of Sydney, Australia.

出版信息

PLoS Med. 2005 May;2(5):e131. doi: 10.1371/journal.pmed.0020131. Epub 2005 May 31.

DOI:10.1371/journal.pmed.0020131

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1140946/

Abstract

There are clear evidence-based guidelines for managing patients at risk of cardiovascular disease, and yet many doctors don't follow these guidelines.

摘要

对于管理有心血管疾病风险的患者，有明确的循证指南，但仍有许多医生不遵循这些指南。